Back
Monte Rosa Therapeutics Stock Predictions
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
34
GLUE
Monte Rosa Therapeutics
Last Price:
8.49
Seasonality Move:
-8.98%
7 Day Trial
ALL ACCESS PASS
$
7
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.Monte Rosa Therapeutics Stock Forecast
- Over the next 52 weeks, Monte Rosa Therapeutics has on average historically risen by 27.5% based on the past 3 years of stock performance.
- Monte Rosa Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Monte Rosa Therapeutics Stock Undervalued?
The current Monte Rosa Therapeutics [GLUE] share price is $8.63. The Score for GLUE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal. - GLUE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Monte Rosa Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Monte Rosa Therapeutics has on average historically risen by 27.5% based on the past 3 years of stock performance.
Monte Rosa Therapeutics Stock Rating
Sell
34
Monte Rosa Therapeutics (GLUE)
is a Sell
Is Monte Rosa Therapeutics overpriced?
- Monte Rosa Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Monte Rosa Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
monterosatx.com
52-Week Data
52-Week High:
12.40
52-Week Low:
2.91
Prediction Charts
Market Cap:
529.34M
Price in USD:
8.63
Volume:
668.88K
Beta:
1.33
Technical Analysis
SMA50:
6.45
SMA100:
5.53
SMA200:
5.53
52-Wk Change:
182.32%
Stock Predictions
-
Is Monte Rosa Therapeutics stock public?
Yes, Monte Rosa Therapeutics is a publicly traded company. -
What is the Monte Rosa Therapeutics stock quote today?
The Monte Rosa Therapeutics stock price is 8.63 USD today. -
How to buy Monte Rosa Therapeutics stock online?
You can buy Monte Rosa Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-25 | 4.93 | 4.89 | 5.11 | 4.85 |
| Oct-28 | 6.39 | 9.48 | 12.40 | 6.15 |
| Oct-29 | 9.34 | 9.37 | 9.52 | 8.35 |
| Oct-30 | 9.47 | 9.22 | 9.68 | 8.91 |
| Oct-31 | 9.24 | 8.50 | 9.54 | 8.50 |
| Nov-1 | 8.35 | 8.90 | 8.94 | 8.31 |
| Nov-4 | 8.91 | 8.83 | 9.12 | 8.49 |
| Nov-5 | 8.85 | 9.36 | 9.37 | 8.42 |
| Nov-6 | 9.68 | 9.46 | 9.70 | 8.90 |
| Nov-7 | 9.50 | 9.53 | 9.85 | 9.32 |
| Nov-8 | 9.82 | 9.26 | 9.85 | 9.00 |
| Nov-11 | 9.50 | 9.99 | 10.40 | 9.32 |
| Nov-12 | 9.93 | 9.12 | 10.22 | 9.00 |
| Nov-13 | 9.36 | 8.63 | 9.60 | 8.62 |
Monte Rosa Therapeutics Earnings
Monte Rosa Therapeutics Earnings Report: Per Share Monte Rosa Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Monte Rosa Therapeutics Forecast Revenue Growth
Monte Rosa Therapeutics Stock Analysis: Historical quarterly revenues per share for Monte Rosa Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and a decrease next year of $0.60 per share.
* Monte Rosa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.